Latest Morning Briefing Stories

Stop Blaming Tuskegee, Critics Say. It’s Not an ‘Excuse’ for Current Medical Racism.

The Tuskegee syphilis study is often cited as a reason Black Americans might hesitate to take the covid-19 vaccine. But many people say that current racism in health care and lack of access deserve more attention to move more Black Americans toward vaccine protection.

Birx Joins Air-Cleaning Industry Amid Land Grab for Billions in Federal Covid Relief

Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.

The Hype Has Faded, but Don’t Count Out Convalescent Plasma in Covid Battle

The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.

Blue Shield Spent Years Cultivating a Relationship with Newsom. It Got the State Vaccine Contract.

Insurance giant Blue Shield of California has made millions in charitable and political donations to Gov. Gavin Newsom over nearly two decades, largely to his dearly held homeless initiatives. In turn, Newsom has rewarded the insurer with a $15 million no-bid contract to lead the state’s covid vaccination distribution.

So You’re Vaccinated Against Covid. Now What?

The vaccination rollout has been unsteady, but the vaccines seem very effective, raising hopes that the pandemic will subside by later this year if enough Americans get their shots. Meanwhile, remain cautious.